Stock comparison
Becton, Dickinson and
Eli Lilly
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BDX
Becton, Dickinson and
Market cap
$53.46B
Sector
Healthcare
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BDX | LLY | Winner |
|---|---|---|---|
| Warren Buffett | 49D | 72B | LLY |
| Benjamin Graham | 57C | 86A | LLY |
| Philip Fisher | 36D | 86A | LLY |
| Peter Lynch | 15F | 74B | LLY |
| Joel Greenblatt | 40D | 78C | LLY |
| Charlie Munger | 39D | 85A | LLY |
| Terry Smith | 39D | 77C | LLY |
Side-by-side metrics
| Metric | BDX | LLY |
|---|---|---|
| Market cap | $53.46B | $1T |
| P/E (TTM) | 35.3x | 36.6x |
| EV/EBIT | 26.5x | 34.1x |
| ROIC (TTM) | 4.1% | 32.06% |
| Gross margin | 46.48% | 83.51% |
| Net margin | 5.33% | 34.98% |
| Revenue CAGR 5y | 3.37% | 23.17% |
| EPS CAGR 5y | -4.15% | 40.81% |
| Debt / Equity | 0.7x | 1.4x |
| Dividend yield | 2.45% | 0.62% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BDX leads on
- Dividend yield2.45%vs 0.62%+75%
- Debt / Equity0.7xvs 1.4x+48%
- EV/EBIT26.5xvs 34.1x+22%
LLY leads on
- EPS CAGR 5y40.81%vs -4.15%+110%
- Market cap$1Tvs $53.46B+95%
- ROIC (TTM)32.06%vs 4.1%+87%
- Revenue CAGR 5y23.17%vs 3.37%+85%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.